It has been shown that the use of Mac-1 (CD11b/CD18) antibodies leads to an improved response to radiation therapy in squamous cell carcinoma xenografts of mice, which is accompanied by reduced infiltration of myeloid cells expressing MMP-9 and S100A8 inside tumors [60]. The gene discussed is ITGAM; the disease is squamous cell carcinoma.